The effect of fish oil versus krill oil intervention on clinical symptoms and cardiometabolic risk factors in patients with major depressive disorder: A randomized placebo-controlled double-blind trial
| dc.contributor.author | Acik, Murat | |
| dc.contributor.author | Cakiroglu, Funda Pinar | |
| dc.contributor.author | Tekin, Atilla | |
| dc.contributor.author | Egeli, Asli | |
| dc.date.accessioned | 2026-08-12T17:41:49Z | |
| dc.date.issued | 2025 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Background: This study aimed to compare the effects of krill- and fish-oil interventions on clinical symptoms and metabolic risk factors in individuals with MDD. Methods: In this randomized study, 57 adults diagnosed with MDD were allocated to receive krill-oil (520 mg EPA + DHA), fish-oil (600 mg EPA + DHA), or a placebo (soybean-oil) daily for 8 weeks. Anthropometric measurements, depression anxiety stress-21 (DASS-21) scale, and Hamilton depression rating scale (HDRS) were performed at baseline and 4 and 8 weeks. In addition, venous blood samples were collected at baseline and postintervention to evaluate lipid and glycemic profiles, including fasting glucose, HbA1c, cholesterol, triglycerides, LDL-c, and HDL-c levels.SPSS and R Studio software programs were used for statistical analysis. Results: A total of 50 participants completed the study, with 17 in each intervention group and 16 in the placebo. The mean HDRS scores decreased significantly in both the krill-oil (8.5 +/- 1.2) and fish-oil groups (10.0 +/- 1.2) compared to the placebo (p < 0.001), indicating clinical symptom improvement. Furthermore, the interaction effect of group-by-time was found to be statistically significant (eta 2p = 0.273;ptimexgroup < 0.001). Anxiety and distress scores decreased to similar levels after the post-intervention compared to baseline in krill- and fish-oil groups. Krill- and fish-oil supplementation increased plasma HDL-c and uric acid levels, but the group-by-time interaction effect was only observed at the HDL-c level (eta 2p = 0.238;ptimexgroup = 0.002). The mean HbA1c rates and plasma triglyceride levels of krill-oil recipients were lower after the post-intervention. Conclusion: Krill- and fish-oil could be considered as a safe and effective adjuvant treatments for depression. However, there was no evidence of apparent superiority over each other. | |
| dc.identifier.doi | 10.1016/j.jad.2025.03.097 | |
| dc.identifier.endpage | 180 | |
| dc.identifier.issn | 0165-0327 | |
| dc.identifier.issn | 1573-2517 | |
| dc.identifier.orcid | 0000-0002-3104-6306 | |
| dc.identifier.orcid | 0000-0002-2281-6719 | |
| dc.identifier.orcid | 0000-0003-2324-6874 | |
| dc.identifier.pmid | 40118278 | |
| dc.identifier.scopus | 2-s2.0-105000708161 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 171 | |
| dc.identifier.uri | https://doi.org/10.1016/j.jad.2025.03.097 | |
| dc.identifier.uri | https://hdl.handle.net/11508/59493 | |
| dc.identifier.volume | 380 | |
| dc.identifier.wos | WOS:001457277300001 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.relation.ispartof | Journal of Affective Disorders | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | Depression | |
| dc.subject | N-3 PUFAs | |
| dc.subject | Anxiety | |
| dc.subject | Distress | |
| dc.subject | Metabolic risk factors | |
| dc.title | The effect of fish oil versus krill oil intervention on clinical symptoms and cardiometabolic risk factors in patients with major depressive disorder: A randomized placebo-controlled double-blind trial | |
| dc.type | Article |







